Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene ther... Read more
MarketWatch
CNBC
CNBC
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.